Hypertension |
ACTRN12617001533381p: Combination low dose blood pressure lowering treatment for patients with untreated hypertension |
|
|
| Not yet recruiting | 4 | 12 | | | George Medicines, George Medicines (The George Institute) | Hypertension | | | | |
ACTRN12617001533381: Combination low dose blood pressure lowering treatment for patients with untreated hypertension |
|
|
| Not yet recruiting | 4 | 12 | | | George Medicines, George Medicines (The George Institute) | Hypertension | | | | |
| Not yet recruiting | 4 | 15 | | | Actelion Phrmaceuticals Australia, Actelion Phrmaceuticals Australia | Hypertension, Pulmonary | | | | |
ACTRN12616001088437p: Does locally produced Enalapril (Envas) work as well as imported Enalapril (EnaDenk) in the treatment of individual patients with hypertension? Addis Ababa, Ethiopia |
|
|
| Not yet recruiting | 4 | 30 | | | University of Queensland, University of Queensland | Hypertension | | | | |
ACTRN12616001088437: Does locally produced Enalapril (Envas) work as well as imported Enalapril (EnaDenk) in the treatment of individual patients with hypertension? Addis Ababa, Ethiopia |
|
|
| Not yet recruiting | 4 | 30 | | | University of Queensland, University of Queensland | Hypertension | | | | |
ACTRN12624000883516: Safety of ibuprofen to manage pain after caesarean section for women who have hypertension in pregnancy - a randomised pilot study |
|
|
| Not yet recruiting | 4 | 80 | | | Royal North Shore Hospital , Ramsay Healthcare- Ramsay Research and Education Grant | chronic hypertension
, Preeclampsia, gestational hypertension | | | | |
ACTRN12622000391774p: A Randomised trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER) |
|
|
| Not yet recruiting | 4 | 100 | | | Dr Jun Yang, Dr Jun Yang | Low-renin hypertension | | | | |
ACTRN12614000461695: Assessment of the Effects of Cardiopulmonary Phenotype on Oral and intravenous (IV) Frusemide Pharmacokinetics |
|
|
| Recruiting | 4 | 20 | | | Flinders University, Flinders University | Congestive Heart Failure, Pulmonary Hypertension | | | | |
ACTRN12610001024033: Safety and Benefits of A Tablet Combining Losartan and Hydrochlorothiazide in Hypertensive Patients with Diabetes |
|
|
| Recruiting | 4 | 30 | | | Keio University School of Medicine, Keio University School of Medicine | diabetic patients with hypertension | | | | |
ACTRN12608000371392: A Randomised Controlled Trial of Medical Prophylaxis for the Prevention of Hypertension, Renal Disease and Diabetes in Australian Aborigines |
|
|
| Recruiting | 4 | 200 | | | The University of Queensland, Colonial Foundation Limited, NHMRC- National Health and Medical Research Council | Diabetes, Hypertension, Renal Disease | | | | |
| Active, not recruiting | 4 | 462 | | | Kinitoshi Iseki | chronic hemodialysis patients (3/week), Hypertension | | | | |
| Ongoing | 4 | 704 | Europe | Methylprednisolone acetate, Triamcinolone acetonide, Injection, Solution for injection, Depo-Medrone, Kenalog | University of Oxford, NIHR Health Technology Assessment Programme | Pulmonary Hypertension, Right heart failure | | | | |
| Ongoing | 4 | 80 | Europe | Film-coated tablet, Losartan potassium, Perindopril Arginine | Monash Medical Centre , Monash University Health Practitioner Research Fellowship | The pharmacokinetics of oral creatine monohydrate (CrM) dosing in pregnancy, Metabolism of nutraceutical supplement (creatine monohydrate) in pregnancy | | | | |
2021-000880-63`ACTRN12609000047291: COVID-19 vaccine in patients with rheumatic diseases: The impact of treatments on the vaccine response protection against infection (COVID19-REUMA) COVID19 vaccin hos patienter med reumatiska sjukdomar: effekter av behandlingen på vaccinsvar och skydd mot infektion |
|
|
| Ongoing | 4 | 868 | Europe | Comirnaty, COVID-19 Vaccine AstraZeneca, COVID-19 Vaccine Moderna, Injection, Comirnaty, COVID-19 Vaccine AstraZeneca, COVID-19 Vaccine Moderna | Skåne University Hospital, department of rheumatology in Lud and Malmö, Skåne University Hospital, Department of rheumatology in Lund and Malmö | Pre-hypertension | | | | |
ACTRN12622000391774: A Randomised trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER) |
|
|
| Recruiting | 4 | 100 | | | Dr Jun Yang, Dr Jun Yang | Low-renin hypertension | | | | |
ChiCTR-ONC-11001612: Observational investigation in hospital of Songling Xuemaikang Capsule for treating primary hypertension, a real word study |
|
|
| Recruiting | 4 | 5000 | | Songling Xuemaikang Capsule | Dongzhimen Hospital; Dongzhimen Hospital, Pharmaceutical Co., Ltd. Chengdu Nakasone | primary hypertension | | | | |
ChiCTR-OCH-12002780: Clinical observation on curative effect of uniting use of Capsules of compound Cortex Moutan & Leech and Aspirin on improving the prethrombotic state in patients with Type 2 diabetes mellitus and hypertension |
|
|
| Completed | 4 | 150 | | Add a Dan vermiculite hypoglycemic capsule ;Add a Dan vermiculite hypoglycemic capsule | Senium Vasculocardiology Deparment, The first affiliated hospital of TCM college of Anhui province; The first affiliated hospital of TCM college of Anhui province, The special topic fund of TCM Science and Technology study of The State Administration of Traditional Chinese Medicine.( 06-07LP22) | Diabetes mellitus AND Cardiovascular disease | | | | |
2005-004288-47: Etude des effets d'un antagoniste calcique(la barnidipine) sur la sensibilité des chémorécepteurs et l'activité orthosympathique. |
|
|
| Ongoing | 4 | 24 | Europe | Vasexten, Capsule*, Vasexten | Hôpital Erasme | 2 groups of patients: one group of patients with systemic hypertension and one another group with control subjects free of disease | | | | |
2006-002065-39: Primaarin ja sekundaarisen hypertension hemodynamiikka: DYNAMIC–tutkimus |
|
|
| Ongoing | 4 | 1000 | Europe | Sublingual tablet, Inhalation vapour, liquid, Nitro, Ventoline evohaler | Ilkka Pörsti ja tutkimusryhmä | Terveet vaapaaehtoiset Primaari hypertensio Sekundaari hypertensio Munuaisten vajaatoiminta Ateroskleroottinen valtimosairaus | | | | |
2006-003133-33: Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe. |
|
|
| Ongoing | 4 | 20 | Europe | Tablet, Tracleer | Hôpital Erasme | healthy subjectsobstructive sleep apnea(Bosentan is used in clinic in pulmonary hypertension) | | | | |
ChiCTR-TRC-08000251: Percutaneous Transhepatic Variceal Embolization versus Endoscopic Injections with Histoacryl for the treatment of gastric fundus varices: A Randomized Controlled Trial |
|
|
| Completed | 4 | 72 | | Patients has gastroscopy to investigate the degree of gastric fundus varices; Histoacryl blue injection was performed using an Olympus electronic gastroscope and a disposable injection needle. Each shot contained 0.5ml Histoacryl and 0.5ml Lipiodol. Last the needles were rinsed with 5% Glucose. ;The included patients was performed PTVE by venipuncture, intubation tube, visualization, histoacryl was then injected continuously until all the gastric fundus varices and opacified. During withdrawal of the sheath, the needle tract was closed with gelatin sponge or stainless-steel coils. | Shandong Provincial Hospital; Shandong University, Shandong Province Key Scientific and Technological Projects | liver cirrhosis; portal hypertension; gastric fundus varices; alimentary tract hemorrhage | | | | |
ChiCTR-TRC-09000538: The study on pathogeny of hypertension and the salt intervention on diet in the population of Zhangwu County |
|
|
| Completed | 4 | 541 | | take salt with lower Natrium ;take common Iodine salt | The First Hospital of China Medical University; Level of the institution:, Science and technology projects of Liaoning Province | Hypertension | | | | |
2007-005655-42: STUDY TITLE: - Early Metabolic Changes with Thiazide or Beta blocker Therapy for Essential Hypertension – open label extension phase with the potassium sparing diuretic- Amiloride. |
|
|
| Ongoing | 4 | 60 | Europe | Amiloride hydrochloride, Tablet, No trade name (Generic amiloride hydrochloride) | Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital | Essential hypertension | | | | |
ChiCTR-TRC-10001071: The Effect of Amlodipine and Valsartan in Hypertensive Renal Post-transplant Patients |
|
|
| Completed | 4 | 150 | | amlodipine(Norvase, 5mg/tablet) + metoprolol(Betaloc,12.5mg/tablet) ;valsartan(Diovan, 80mg/tablet) +metoprolol(Betaloc,12.5mg/tablet) | the Third Xiangya Hospital of Central South University; Hunan Science and Technology Bureau, Science and Technology Program of Hunan (2006SK2003) | Post-transplant hypertension | | | | |
| Completed | 4 | 6000 | | Health education + treating for antihypertention + treating for decreasing lipid; Health education + treatment for antihypertention; Health education | Shengjing Hospital of China Medical University; The Department of Science and Technique, Liaoning Province Government, The Department of Science and Technique, Liaoning Province Government | stroke | | | | |
ChiCTR-TRC-08000242: The mechanisms and effects on organ protection of combination of nitric oxide gas and iloprost during cardiopulmonary bypass |
|
|
| Completed | 4 | 60 | | routine CPB plus NO plus iloprost ;routine CPB plus iloprost ;routine CPB plus NO ;routine CPB not taking any drugs | Department of Thoracic and Cardiovascular Surgery, West China Hospital; The National Natural Science Fundation, The National Natural Science Funds | isolated atrial septal defects and/or ventricular septal defects with/without pulmonary hypertension | | | | |
| Completed | 4 | 60 | | basic treatment + atorvastatin ;basic treatment | Tongji Hospital of Tongji University; Level of the institution:, the study for Doctor's degree | pulmonary embolism and chronic thromboembolic pulmonary hypertension | | | | |
ChiCTR-TRC-09000426: Randomized controlled trial of losartan\propranolol in treating portal hypertension |
|
|
| Completed | 4 | 90 | | Oral losartan by 25mg/d of the initial dose, three days latter alternate to 50mg/d ;Oral propranolol by 20mg/d of initial dose; then, progressively increase 10mg/d, max dose 120mg/d or rest heart rate reduced to the 75% of fundamental rate, or no less than 55/min ;Placebo | Department 1 of Infectious Diseases, 302 Hospital of P.L.A; Level of the institution:, self-finance | portal hypertension | | | | |
| Completed | 4 | 60 | | After an overnight fast, the subjects ingested a single 40mg dose of telmisartan with 250ml water | Central South University; Level of the institution:, Self-financing | Hypertension | | | | |
CHIEF, ChiCTR-TRC-08000087: Randomised trial of initial low-dose CCB and ARB combination in Chinese hypertension patients (updated in February 5 2009) |
|
|
| Completed | 4 | 24000 | | (Total Cholesterol concentration of participants: <4.0 or >6.1mmol/L). Amlodipine 2.5mg and compound amiloride half of a tablet. ;(Total Cholesterol concentration of participants <4.0 or >6.1mmol/L). Amlodipine 2.5mg and telmisartan 40mg. ;(Total Cholesterol concentration of participants: 4.0-6.1mmol/L). Amlodipine 2.5mg, telmisartan 40mg and simvastatin 10mg. ;(Total Cholesterol concentration of participants: 4.0-6.1mmol/L). Amlodipine 2.5mg and telmisartan 40mg, regular remedy of serum lipid decided by the doctors. ;(Total Cholesterol concentration of participants 4.0-6.1mmol/L). Amlodipine 2.5mg and compound amiloride half of a tabella and regular remedy of serum lipid decided by the doctors. ;(Total Cholesterol concentration of participants: 4.0-6.1mmol/L). Amlodipine 2.5mg, compound amiloride 2.5mg and simvastatin 10mg ;(Includes group 1, group 2, and group 5). Amlodipine 2.5mg, compound amiloride half of a tablet. ;(Includes group 3, group 4 and group 6). Amlodipine 2.5mg, telmisartan 40mg. | Fu Wai Hospital for Cardiovascular Disease; The Ministry of Science and Technology of the People's Republic of China, The Ministry of Science and Technology of the People's Republic of China | Hypertension | | | | |
ChiCTR-TRC-08000041: A randomized controlled trial of Selective Decongestive Devascularization Shunt of Gastrosplenic Region and Pericardial Devascularization with Splenectomy in the treatment of portal hypertension |
|
|
| Completed | 4 | 160 | | SDDS-GSR operation ;PCDV operation | No.1 Hospital Affiliated to Wenzhou Medical College; Scientific Foundation of Zhejiang Province and Wenzhou Scientific and Technologic Bureau, Scientific Foundation of Zhejiang Province and Wenzhou Scientific and Technologic Bureau | Portal hypertension due to liver cirrhosis | | | | |
ChiCTR-TRC-10001128: Standardized study of integrated traditional Chinese and western medicine on the treatment of senile hypertension |
|
|
| Completed | 4 | 300 | | the control group are given extended release nifedipine tablets 10mg bid and Enalapril Maleate Tablets 10mg bid.and if the participent couln't resist the adverse reaction,change to indapamide tablet 2.5mg qd. ;on the basic medication of the control group ,the treatment group are given different herbal medicine according to the syndrome differentiation | Xiyuan Hospital of Chinese Academy of Medical Science; State Administration of Traditonal Chinese Medicine of The People’s Republic of China, National Key Technology R&D Program of China | senile hypertension | | | | |
| Completed | 4 | 600 | | Levamlodipine Besylate ;Losartan | Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing; Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing, hospital administration funds | IFG and Hypertension | | | | |
ChiCTR-OCH-12002611: Genetic polymorphisms affect therapeutic response to angiotensin-converting enzyme inhibitors in Chinese hypertensive patients |
|
|
| Completed | 4 | 1000 | | no ;antihypertensive drug | Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, Self-financing | Hypertension | | | | |
ChiCTR-TRC-10001091: 7-day hemodynamic response to carvedilol combined with isosorbide mononitrate (ISMN) versus carvedilol alone in cirrhotic patients: a randomized controlled trial |
|
|
| Completed | 4 | 100 | | Carvedilol, orally taken for 7 days. The initial dosage is 12.5mg once daily, and the dosage is modulated for the target that the heart rate reduces below 55 per minute or the reduction > 20% of the baseline heart rate. Keep the systolic blood pressure ≥90mmHg. Once hypotension occurs, reduce the dosage at once and drug withdrawl is required if necessary. ;Carvedilol+Isosorbide Mononitrate Sustained Release Tablets, orally taken for 7days. The initial dosage of carvedilol is 12.5mg once daily, and ISMN 30mg daily. The dosage is modulated for the target that the heart rate reduces below 55 per minute or the reduction > 20% of the baseline heart rate. once hypotension occurs, reduce the dosage at once and drug withdrawl is required if necessary. | Shandong Provincial Hospital; Level of the institution:, Self-fianace | portal hypertension | | | | |
ChiCTR-PRC-08000217: CHINOM, sub-project of CHIEF, a project of The National 11th Five-year plan, Science-Technology Ministry |
|
|
| Completed | 4 | 4800 | | telmesartan capsule 40mg/day ;Beijing 0 tablets 0.5#/qd ;placebo tablets 0.5#/qd ;Indapamide 1.5mg/capsule, once two days | Beijing Double-Crane Pharmaceutical Co., Ltd.; Ministry of Science and Technology of The People's Republic of China, 11th National Five-Year Plan + Sponsorship | Hypertension, Cardiovascular diseases | | | | |
2011-005545-12: ENCHANTED: A Trial to assess the effects of low- vs standard-dose clot-busting and intensive vs standard blood pressure-lowering treatments on outcome after acute ischaemic stroke |
|
|
| Ongoing | 4 | 5000 | Europe | Actilyse, Labetalol, Glyceryl trinitrate, Glyceryl Trinitrate, Powder and solvent for solution for infusion, Powder and solvent for solution for injection/infusion, Solution for injection, Transdermal patch, Solution for infusion, Actilyse, Labetalol | University of Leicester, National Health and Medical Research Council | Acute Ischaemic Stroke, Stroke or 'Brain Attack' caused by a clot., Diseases [C] - Nervous System Diseases [C10] | | | | |
ChiCTR-TRC-11001663: Administration time-dependent effects of aspirin on blood pressure variance and morning blood pressure peak of nonhypertension patients with coronary heart disease |
|
|
| Completed | 4 | 30 | | Besides the basic treatment aspirin on awakening for 2weeks and then taking aspirin at bedtime for 2 weeks ;aspirin at bedtime for 2weeks,and then taking aspirin on awakening for 2weeks. | The Second Hospital of Hebei Medical University; The Second Hospital of Hebei Medical University, Department of Cardiology | coronary heart disease | | | | |
| Completed | 4 | 4100 | | acarbose | The General Hospital of the People's Liberation Army (PLAGH); The General Hospital of the People's Liberation Army (PLAGH), Bayer healthcare | Hypertension and ischemic heart disease | | | | |
ChiCTR-OCH-12002710: Pharmacogenetics study of hydrochlorothiazide and felodipine in Chinese hypertensive patients |
|
|
| Completed | 4 | 1325 | | Hydrochlorothiazide ;Hydrochlorothiazide+Felodipine | Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, 863 project | Hypertension | | | | |
ChiCTR-TRC-08000320: Fixed-dose Combination for Antihypertensive Therapy in the Community Healthcare |
|
|
| Completed | 4 | 750 | | FUFANGJIANGYAPIAN 1 TABLET, 1 TABLET TID PO ;FUFANGJIANGYAPIAN 1 TABLET, 1 TABLET TID PO | Fuwai Hospital; Beijing ShuangHe pharmaceutical company, Enterprise funded | hypertension | | | | |
ChiCTR-PRNC-12002690: Effects of CACNA1C, eNOS, and RGS2 gene polymorphisms on the antihypertensive response of dihydropyridine calcium channel blockers in patients with essential hypertension. |
|
|
| Completed | 4 | 70 | | antihypertension drugs | Institute of Clinical Pharmacology in Central South Univiersity; Institute of Clinical Pharmacology in Central South Univiersity, the "863" Project (No. 2012AA02A518) | essential hypertension | | | | |
ChiCTR-RCH-12002864: Relationship between genetic polymorphisms and adverse reaction of antihypertensive drugs in patients with essential hypertension |
|
|
| Completed | 4 | 1600 | | no ;antihypertensive drugs | Institute of Clinical Pharmacology, Central South University; 湖南长沙市湘雅路110号中南大学临床药理研究所, 863 project | Hypertension | | | | |
ChiCTR-TRC-10001142: Early intervention with supplemental of vitamin D in patients with primary hypertension and vitamin D deficiency |
|
|
| Completed | 4 | 200 | | Calcium (600mg/d)+vitamin D (800IU/d) ;Calcium (1200mg/d)+vitamin D (400IU/d) ;Calcium (600mg/d)+vitamin D (400IU/d) ;Calcium (1200mg/d)+vitamin D (800IU/d) | The first hospital affiliated to Xinjiang Medical University; The first hospital affiliated to Xinjiang Medical University, Evidence-based medicine special fund of the first hospital affiliated to Xinjiang Medical University | primary hypertension | | | | |
ChiCTR-ONC-11001799: A single center, open lable clinical study of bosentan therapy in pediatric patients with severe pulmonary arterial hypertension due to congenital heart disease |
|
|
| Completed | 4 | 50 | | Bosentan therapy | Beijing Anzhen Hospital; Beijing Anzhen Hospital, Actelion Pharmaceuticals Ltd | pediatric patients with severe pulmonary arterial hypertension due to congenital heart disease | | | | |
ChiCTR-ONC-11001645: Nitrendipine/atenolol combination tablets anti-hypertension treatment in community healthcare |
|
|
| Completed | 4 | 9000 | | The enrolled patients aged 18-70 will be treated with nitrendipine/atenolol combination tablets for 6 months(some of them will be treated for 12 months). The initial dose comprised two tablets of nitrendipine(5 mg)/atenolol(10 mg) between 8:00 am and 10:00 am once a day.; If the blood pressure is higher than that of baseline at the end of the second week, the drugs may increase to 3 tablets(taking an additional tablet of drug at about 18:00 pm). If the blood pressure are poor controlled (≥ 140/90 mmHg) at the end of the fourth week, the drugs taken in the afternoon may increase to 2 tablets.; If the blood pressure are poor controlled (≥ 140/90 mmHg) at the end of the second month, the patients may take other antihypertensive drugs (other CCB and β-blockers are not allowed to take). If dose-related intolerance symptoms, suspected or definite low blood pressure occur in patients,the drugs taken may be reduced gradually. | The Beijing Hypertension League Institute; Fuwai Hospital PUMC & CAMS, Jiangsu Jiberer Pharmaceutical Company Limited | Primary hypertension | | | | |
| Completed | 4 | 45 | | 0.9%saline muscular injection monthly ;20mg long-acting octreotide muscular injection mon ;40mg long-acting octreotide muscular injection mon | Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, none | portal hypertension | | | | |
| Completed | 4 | 400 | | All eligible subjects will receive OLM 20mg/d additionally on the treatment of AML 5mg/d to lower the blood pressure at least for 8 weeks. If target blood pressure (SeDBP<90mmHg, SeDBP<80mmHg for DM subjects) is not achieved, up titrate to OLM 40mg/d with AML 5mg/d or add HCTZ 12.5mg/d on OLM 20mg/d (fixed combination tablet of OLM/HCTZ) and AML 5mg/d according to the judgment of investigators. | Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School; Daiichi Sankyo Pharmaceutical (Shangjhai) Co., LTD., Daiichi Sankyo Corporation | Hypertension | | | | |
2013-002000-14: De effecten van een rechter paravertebraal blok op de werking van het hart bij patiënten met pulmonale hypertentie die minimaal invasieve mitralisklepchirugie ondergaan. |
|
|
| Ongoing | 4 | 50 | Europe | Chirocaine, Solution for injection, Chirocaine | University Hospitals Leuven, University Hospitals Leuven | patients with pulmonary hypertension scheduled for elective minimally invasive mitral valve surgery using heartport technique., patients with pulmonary hypertension scheduled for elective minimally invasive mitral valve surgery using heartport technique., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] | | | | |
ChiCTR-OCH-12002769: Pharmacogenomics study of telmisartan and indapamide in patients with essential hypertension |
|
|
| Completed | 4 | 1800 | | telmisartan ;ndapamide | Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, 863 project | Hypertension | | | | |
ChiCTR-ONC-12002826: Perioperative Use of Inhaled and Intravenous Iloprost in Patients with Pulmonary Hypertension during Non-cardiac Surgery |
|
|
| Completed | 4 | 30 | | Iloprost Inhalation | Beijing Shijitan Hospital, Capital Medical University; Beijing Shijitan Hospital, Capital Medical University, Self-financing | Patients with Pulmonary Hypertension | | | | |
ChiCTR-TRC-11001781: A multi-centre study of urapidil versus nitroglycerin in the treatment of AHF patients with hypertension |
|
|
| Completed | 4 | 300 | | Urapidil injection titrated to target dose within 6 hours. Treatment lasts for 48 hours. | Department of Cardiology, Xuanwu Hospital, Capital Medical University; China International Medical Communicational Foundation, Funds obtained from collaboration project | Acute Heart Failure with hypertension | | | | |
ChiCTR-TRC-12001910: An investigation for blood 25 (OH) D concentration and intervention study in hypertension population with low serum 25 (OH) D concentration in Urumqi |
|
|
| Completed | 4 | 400 | | Calcium antagonists and Calcitriol capsule treatme ;Calcium antagonists and Calcitriol placebo capsule treatme | The First Affiliated Hospital of Xinjiang Medical University; Urumqi Science and Technique Committee, science and technology plan projects special fund in Urumqi | Hypertension | | | | |
2014-000605-12: Comparison of two drugs against high blood pressure in dermatology patients. Vergelijking van twee medicijnen tegen hoge bloeddruk bij dermatologie patiënten. |
|
|
| Ongoing | 4 | 15 | Europe | Tablet, Amlodipine, Chlortalidone | | Hypertension, induced by the use of a Calcineurin Inhibitor (CNI) Hypertensie, geïnduceerd door het gebruik van een Calcineurine Remmer (CNI), Hypertension, high blood pressure Hypertensie, hoge bloeddruk, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
PADN-2, ChiCTR-TRC-12002097: Pulmonary Artery Denervation in Patients with Pulmonary Artery Hypertention (The trial): a randomised controlled trial |
|
|
| Completed | 4 | 56 | | pulmonary artery renovation ;pharmacotherapy | Nanjing First Hospital, Nanjing Medical Hospital; Nanjing First Hospital, Nanjing Medical Hospital, Jiangsu Provincial Outstanding Medical Program | Pulmonary artery hypertension | | | | |
2014-000091-25: A single-centre, placebo-controlled, double-blinded, randomized, cross-over study of Iloprost (Ventavis®) in patients with Eisenmenger syndrome |
|
|
| Ongoing | 4 | 15 | Europe | Ventavis, Inhalation solution, Iloprost | Royal Brompton and Harefield NHS Foundation Trust, Bayer PLC | Pulmonary Arterial Hypertension Eisenmenger syndrome, PAH Eisenmenger, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
ChiCTR-TRC-12002925: Research on the mechanisms of uric acid in development of hypertension among pre-hypertension based on metabenomic techniques |
|
|
| Completed | 4 | 1500 | | No intervention ;diet intervention ;No intervention | Tianjin Medical University General Hospital; Level of the institution:, Science Foundation of Tianjin Medical University | hypertension | | | | |
ChiCTR-TRC-13003690: The effection and mechanism of Fudosteine used in hypertension patients company with obstructive sleep apnea |
|
|
| Completed | 4 | 120 | | patients treated with drug A(Fudosteine or placebo ;patients treated with drug A(Fudosteine or placebo) | Jiangsu Geriatric Hospital; Level of the institution:, Project of 2012 Jiangsu provincial clinical medicine technology | hypertension complicated with obstructive sleep apnea syndrome | | | | |
ChiCTR-TRC-14005001: Heart Rate Variability Biofeedback Intervention on the Stress Response of Prehypertensives |
|
|
| Completed | 4 | 32 | | slow abdominal breathing ;HRV-biofeedback ;Nil | Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University; Zhongshan School of Medicine, Sun Yat-sen University, This work has been supported by the Fund of Science and Technology projects in Guangdong Province (No.2010B031600075) | Prehypertension | | | | |
ChiCTR-TRC-14004782: The clinical research on the influence of Bai‘ai capsule on hypertension associated with the metabolic syndrome |
|
|
| Recruiting | 4 | 300 | | Basic treatment (Irbesartan 150mg each time, once a day) + Bai'ai capsules (0.5g each tablet) 3 tablets each time, 2 times a day, taking pills in the morning and 0.5-1 hours after dinner,last for 12 consecutive weeks. ;Basic treatment (Irbesartan 150mg each time, once a day) + placebo (0.5g each tablet) 3 tablets each time, 2 times a day, taking pills in the morning and 0.5-1 hours after dinner,last for 12 consecutive weeks. | Affiliated Huashan Hospital of Fudan University; Level of the institution:, Fund of Shanghai Association of Integrative Medicine | Hypertension associated with the metabolic syndrome | | | | |
NCT06605326: Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study |
|
|
| Completed | 4 | 46 | NA | Subcutaneous Treprostinil | Guangzhou Institute of Respiratory Disease | Pulmonary Hypertension, Pulmonary Arterial Hypertension, Chronic Lung Disease-Associated Pulmonary Hypertension, Lung Transplantation, Heart Failure | 09/24 | 09/24 | | |
ChiCTR-OPN-15005827: The influence of amlodipine/atorvastatin single pill therapy in patients of newly diagnosed hypertension and dyslipidemia on vascular endothelial function and endothelial microparticle |
|
|
| Completed | 4 | 25 | | amlodipine/atorvastatin 5mg/10mg | Peking university third hospital cadiology department; Peking university third hospital, National Natural Science Foundation of China (No: 81300076); the Beijing Natural Science Foundation (No: 7132195); Hisun Pfizer Inc researchers sponsored funds (number: WS1931003) | hypertension and hyperlipidemia | | | | |
| Ongoing | 4 | 72 | Europe | Allopurinol, n/a, Capsule, hard | University of Dundee/ NHS Tayside | right ventricular hypertrophy associated with COPD or Interstitial Lung Disease and pulmonary hypertension, COPD or Interstitial Lung Disease with enlarged right side of heart, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ChiCTR-IPR-14005491: The effect of telmisartan on the pharmacokinetics and pharmacodynamics of metformin |
|
|
| Recruiting | 4 | 32 | | telmisartan | Institute of Clinical Pharmacology, Xiangya Hospitol, Central South University; Institute of Clinical Pharmacology, Central South University, 863 project | Hypertension | | | | |
| Completed | 4 | 300 | | Drug intervention | Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School; Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, self-financiing | small vessel disease | | | | |
AHOCEP, ChiCTR1900021852: Efficacy of Arotinolol Hydrochloride on Major Adverse Cardiovascular Events in Hypertensive Hemodialysis Patients: An Open-label Randomized Controlled Trial |
|
|
| Completed | 4 | 300 | | Routine treatment combined with arotinolol ;Routine treatment | Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., Sumitomo Pharmaceuticals (Suzhou) Co.,Ltd. | End-stage renal disease on maintenance hemodialysis with hypertension | | | | |
ChiCTR-ONC-13004063: Early Intervention Study of Nifedipine Controlled Release Tablets on Mild Hypertension Patients with High PWV |
|
|
| Completed | 4 | 120 | | Nifedipine Controlled Release Tablets | the Second Hosptial of Hebei Medical University; Bayer (China) Ltd, Secondary sponsor | Hypertension | | | | |
2014-002988-16: Using Milrinone in babies with high blood pressure in the lungs soon after birth |
|
|
| Ongoing | 4 | 20 | Europe | Primacor 1mg/ml Solution for Injection, Solution for injection/infusion, Primacor 1mg/ml Solution for Injection | Royal College of Surgeons in Ireland, The Rotunda Hospital | Persistent Pulmonary Hypertension of the Newborn, High Blood Pressure in the Lungs of Newborn Babies, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | | | | |
ChiCTR-TRC-12002642: Upstream Therapeutic Strategies of Valsartan and Fluvastatin on Hypertension Patients with Non-chronic Atrial Fibrillation |
|
|
| Completed | 4 | 2000 | | Valsartan ;fluvastatin & CCB ;valsartan & fluvastatin ;CCB | The second hospital of Tianjin Medical University; Level of the institution:, Unit self-finance, financial appropriation | Hypertension Patients with Atrial Fibrillation | | | | |
ChiCTR-TRC-14004384: Long-acting Octreotide Prevents Variceal Rebleeding in Patients with Portal Hypertension |
|
|
| Completed | 4 | 75 | | 0.9%saline muscular injection monthly ;20mg long-acting octreotide muscular injection monthly ;40mg long-acting octreotide muscular injection monthly | Shanghai Sixth People's Hospital; Level of the institution:, self-funding | liver cirrosis, portal hypertension | | | | |
ChiCTR-IIR-17010892: Long-term observation of using high Selective beta1 receptor blockeron for stable COPD combined with hypertension |
|
|
| Completed | 4 | 81 | | β 1-blocker treatment ;General treatment | Sichuan Provincial People's Hospital; Sichuan Provincial People 's Hospital, no | COPD | | | | |
2004-002232-26: CHANGES IN GLOMERULAR HEMODINAMICS PARAMETERS IN HIPERTENSIVE PATIENTS AFTER TREATMENT WITH LERCANIDIPINE |
|
|
| Ongoing | 4 | 10 | Europe | LERCANIDIPINE, ZANIDIP, ZANIDIP | HOSPITAL 12 OCTUBRE | HYPERTENSION | | | | |
2004-004329-90: EARLY METABOLIC CHANGES WITH THIAZIDE OR BETA BLOCKER THERAPY FOR ESSENTIAL HYPERTENSION (MAIN STUDY). |
|
|
| Ongoing | 4 | 66 | Europe | ATENOLOL, BENDROFLUMETHIAZIDE, Nebivolol Hydrochloride, Amiloride hydrochloride, Hydrochlorothiazide, N/A, PL 0289/0172, Nebilet, No trade name, Apo-Hydro, Nebilet, No trade name, Apo-Hydro | CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST | ESSENTIAL HYPERTENSION | | | | |
2004-002020-17: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR).(STRATEGIES FOR THE TREATMENT OF ARTERIAL HYPERTENSION. ASSESSMENT OF A COMBINED THERAPY AT FIXED DOSES (LOSARTAN/HYDROCHOLOTHIAZIDE) vs MONOTHERAPY (ESTRATAAR) |
|
|
| Ongoing | 4 | 140 | Europe | COZAAR PLUS (losartán / hydrochlorothiazide), COZAAR PLUS, COZAAR PLUS | Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel | Stage II arterial Hypertension | | | | |
| Ongoing | 4 | 30 | Europe | Prolonged-release tablet | Organisation name was not entered | Præeklampsi komplicerer ca. 2% af alle graviditeter og giver anledning til øget morbiditet og mortalitet for både moder og barn. Syndromet er karakteriseret ved hypertension og proteinuri og kompliceres ofte af yderligere organ-påvirkning.Symptomerne har baggrund i oxidativt stress, inflammation og endotheldysfunktion hos moderen. | | | | |
2005-001004-39: Investigation of combined phosphodiesterase 5 inhibitor and isosorbide mononitrate for the treatment ofresistant hypertension |
|
|
| Ongoing | 4 | 40 | Europe | Viagra, Isosorbide mononitrate, Viagra, Angeze 10 Isosorbide mononitrate 10 mg Kentipine 10 Cibral tablets 10, Angeze 20 mg Isosorbide mononitrate 20 mg Cibral tablets 20 mg, Viagra, Angeze 10 Isosorbide mononitrate 10 mg Kentipine 10 Cibral tablets 10, Angeze 20 mg Isosorbide mononitrate 20 mg Cibral tablets 20 mg | University of Edinburgh | Hypertension | | | | |
2005-003182-16: Blood Pressure Optimisation In Patients With Polycystic Kidney Disease And Hypertension By Rotation Through The Main Therapeutic Classes Of Antihypertensive Drugs. |
|
|
| Ongoing | 4 | 42 | Europe | DOXAZOSIN, BISOPROLOL, LISINOPRIL, AMLODIPINE, CANDESARTAN, BENDROFLUMETHIAZIDE, CARDURA, MONOCOR, ZESTRIL, ISTIN, AMIAS, APRINOX, CARDURA, MONOCOR, ZESTRIL, ISTIN, AMIAS, APRINOX | Addenbrooke\'s Hospital Trust | Polycystic kidney disease | | | | |
2005-001551-38: A study to research if foam sclerotherapy of saphenous trunks can speed up the healing of chronic venous leg ulcers |
|
|
| Ongoing | 4 | 200 | Europe | Fibro-Vein, PL 0398/5000, Fibro-Vein STD Pharmaceutical Products LTD Fields Yard Plough Lane Hereford England HR4 0EL, Fibro-Vein STD Pharmaceutical Products LTD Fields Yard Plough Lane Hereford England HR4 0EL | Gloucestershire Hospitals NHS Foundation Trust | We will include patients with insufficiency of the long and/or short saphenous vein as underlying cause of their venous leg ulcer. These patients may or may not have visible varicose veins of the long and/or short saphenous vein.According to ICD classification:Chronic venous hypertension with ulcer ICD-9-CM-459.31Chronic ulcer of the skin ICD-9-CM-707 | | | | |
2006-000637-35: double blind crossover compariosn of diuretics in young patients with low-renin hypertension |
|
|
| Ongoing | 4 | 30 | Europe | Bendroflumethiazide, Amiloride, Frusemide, Spironolactone, Bendroflumethiazide, Amiloride, Frusemide, Spironolactone, Bendroflumethiazide, Amiloride, Frusemide, Spironolactone | Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust | Low-renin hypertension | | | | |
2006-000523-34: Intensiv ikke-sympatikus aktiverende vasodilaterende behandling hos patienter med mikrovaskulær angina pectoris |
|
|
| Ongoing | 4 | 115 | Europe | Zanidip, Diovan, Doxazosin \"Stada\", Moxonidin \"Alpharma\", Visken, Sparkal, Selo-Zok, Myonil Retard, Isodur, Centyl med kaliumchlorid, Angicor, Zanidip, Diovan, Doxazosin \"Stada\", Moxonidin \"Alpharma\", Visken, Sparkal, Selo-Zok, Myonil Retard, Isodur, Centyl med kaliumchlorid, Angicor | Århus Sygehus | Patienter med hypertension og angina pectoris og ingen signifikante stenoser ved koronararteriografi (KAG). | | | | |
2006-001562-16: Studies of insulin action in patients at increased vascular risk. Modulation by antihypertensive and endocrine replacement therapy. |
|
|
| Ongoing | 4 | 45 | Europe | Captopril, Bendroflumethiazide, Amlodipine, Dehydroepiandrosterone, 13311/0064, 0142/0380, 17780/0216, Captopril 50mg, Bendroflumethiazide 2.5mg, Amlodipine 10mg, Captopril 50mg, Bendroflumethiazide 2.5mg, Amlodipine 10mg | Royal Group of Hospitals Trust | Protocol (a): Essential HypertensionProtocol (b): Hypertension in Type 2 DiabetesProtocol (c): Panhypopituitarism | | | | |
2006-005239-32: Fosfodiesterashämmares akuta hemodynamiska effekter vid pulmonell hypertension och utvärdering av kväveoxid mätningar som icke-invasiv diagnostisk metod |
|
|
| Ongoing | 4 | 50 | Europe | Revatio Cialis Levitra, Revatio Cialis Levitra | Medical Sciences, Akademiska sjukhuset | Pulmonell hypertension med kvarstående förhöjt medeltryck i arteria pulmonalis överstigande 25 mmHg i vila eller >30 mmHg under ansträngning vid hjärtkateterisering definierad av National Institute of Health (NIH). Patienten skriver på för skriftligt samtycke (Informed Consent) Patienten över 18 år | | | | |
2006-005082-19: Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with recent stroke. |
|
|
| Ongoing | 4 | 34 | Europe | Miacardis, Miacardis | Research Innovation Services, University of Nottingham | Patients who have hypertension in the context of recent stroke. | | | | |
2006-005361-19: Evaluation of the efficacy of the dual endothelin 1 receptor antagonist Bosentan in the treatment of Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and in the treatment of Pulmonary Hypertension secondary to sarcoidosis |
|
|
| Ongoing | 4 | 45 | Europe | tracleer, Tracleer, Tracleer | St Georges Hospital | Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and secondary to SarcoidPatients devolop pulmonary hypertension for various reasons, two common causes are Chronic Obstructive Pulmonary disease and Sarcoid. Once developed it may go on to cause right heart failure and severe breathlessness and eventually death.We believe that the use of bosentan may lower the pulmonary hypertension and improve symptoms. | | | | |
2006-003998-27: Cardiovascular and functional consquences of chronic kidney disease in older people |
|
|
| Ongoing | 4 | 150 | Europe | Antiadrenergic agents, peripherally acting, Low Ceiling Diuretics, Thiazides, High Ceiling Diuretics, Beta Blocking Agents, Selective Calcium Channel Blockers with mainly vascular effects, Ace Inhibitors, Plain, Angiotensin II antagonists, Plain, | Derby Hospitals NHS Foundation Trust | Chronic Kidney Disease Hypertension Falls | | | | |
2006-006861-18: Comparison between beta-adrenergic blockers and angiotensin II receptor antagonists for the treatment of late hypertension in patients with repaired aortic coarctation |
|
|
| Ongoing | 4 | 20 | Europe | Atacand, Selokeen, Atacand, Selokeen | Department of Cardiology | Aortic coarctation and late hypertension | | | | |
2006-005406-32: Doppler ultrasound investigation of microvasculature in health and disease |
|
|
| Ongoing | 4 | 120 | Europe | Ramipril, Bendroflumethiazide, Ramipril, Bendroflumethiazide | Belfast City Hospital Trust | Diabetes mellitusHypertension | | | | |
2007-000310-36: Does statin therapy reduce sympathoexcitation in hypertension |
|
|
| Ongoing | 4 | 13 | Europe | Atorvastatin, lipitor, lipitor | Radboud University Medical Center Njmegen | hypertension and sympathoexcitation | | | | |
2006-003473-27: Wirkung von Telmisartan 80 mg im Vergleich zu Valsartan 160 mg auf die Insulinsensitivität (HOMA) - WITEVA - |
|
|
| Ongoing | 4 | 40 | Europe | Diovan / Kinzal, BAY69-9291, Diovan 80/160 Kinzal 40/80, Diovan 80/160 Kinzal 40/80 | MedQuality Forschung GmbH | Hypertension | | | | |
2006-006981-40: Does the underlying haemodynamic abnormality determine response to antihypertensive therapy in patients with hypertension? |
|
|
| Ongoing | 4 | 60 | Europe | Doxazosin, Bisoprolol, Candesartan, Isosorbide mononitrate modified release, Doxazosin, | Cambridge University Hospitals NHS Foundation Trust jointly with University of Cambridge | Essential hypertension | | | | |
2006-004705-26: Safety and Tolerability of Sildenafil in Patients with Eisenmenger Physiology |
|
|
| Ongoing | 4 | 12 | Europe | Sildenafil, Revatio ® 20 mg film-coated tablets, Revatio ® 20 mg film-coated tablets | Imperial College London | Eisenmenger Syndrome (pulmonary hypertension due to congenital heart disease) | | | | |
2005-001214-40: A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity |
|
|
| Ongoing | 4 | 50 | Europe | Atenolol, Atenolol, Nebliet, Atenolol, Nebliet | Imperial College London | Hypertension | | | | |
2006-006733-41: Effet de l’association fixe amlodipine/valsartan sur la Pression artérielle centrale chez des hypertendus essentiels non contrôlés par amlodipine 5mg |
|
|
| Ongoing | 4 | 532 | Europe | Exforge, Amlor, Atenolol, Exforge, Amlor, Atenolol | Novartis Pharma S.A.S. | Hypertension artérielle essentielle | | | | |
2007-005546-20: Systemic effects of mild renal insufficiency: the relation between forearm blood flow and ADMA. |
|
|
| Ongoing | 4 | 60 | Europe | Rosuvastatine, Olmetec, ZD4522, Crestor, Olmetec, Crestor, Olmetec | academisch ziekenhuis Maastricht | hypertensionmild renal insufficiency | | | | |
2008-000804-10: Valsartan 160 mg and hydrochlorothiazide 25 mg in subject suffering from arterial hypertension stage 1 or high normal with organ damage |
|
|
| Ongoing | 4 | 20 | Europe | CORIXIL, CORIXIL | UNIVERSITA, DEGLI STUDI DI NAPOLI FEDERICO II | Arterial Hypertension with organ damage | | | | |
2008-001192-29: “Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”\"Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction\" |
|
|
| Ongoing | 4 | 24 | Europe | INSPRA (eplerenona), ALDACTONE, INSPRA (eplerenona), ALDACTONE (espironolactona), INSPRA (eplerenona), ALDACTONE (espironolactona) | Fundación Investigación y Desarrollo en el Area Cardiovascular | Disfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension. | | | | |
2008-002681-63: DOES VITAMIN D REDUCE BLOOD PRESSURE AND LV MASS IN RESISTANT HYPERTENSIVE PATIENTS WITH VITAMIN D INSUFFICIENCY? |
|
|
| Ongoing | 4 | 74 | Europe | Cholecalciferol, Vigantol, Vigantol | Research and Innovation Services, University of Dundee | Resistant Hypertension | | | | |
2008-001509-40: Effects of beta blockers on central arterial pressure and vascular stiffness |
|
|
| Ongoing | 4 | 60 | Europe | Nebilet, Talliton, Betaloc Zok, Nebilet, Talliton, Betaloc Zok | Hungarian Kidney Foundation | Patients with hypertension and/or ischemic heart disease | | | | |
2008-004534-24: Can high-dose vitamin D supplementation reduce blood pressure and markers of cardiovascular risk in older people with isolated systolic hypertension? |
|
|
| Ongoing | 4 | 180 | Europe | Cholecalciferol, Vigantol, Vigantol | University of Dundee | Isolated systolic hypertension | | | | |
2008-007516-15: Comparaison des effets du nébivolol et de l\'aténolol sur la fonction endothéliale vasomotrice des artères de conductance lors de l\'hypertension artérielle essentielle |
|
|
| Ongoing | 4 | 100 | Europe | NEBILOX, ATENOLOL BIOGARAN 50 mg, NEBILOX, ATENOLOL BIOGARAN 50 mg | Laboratoires NEGMA | Hypertension artérielle | | | | |